బీజింగ్ గోబ్రోడ్ హాస్పిటల్

బీజింగ్ గోబ్రోడ్ హాస్పిటల్ is a research hospital that specializes in diagnosing and treating complex and severe cases, performing clinical research, and strategically reforming the biomedicine and medical device industries. It provides a public service platform for clinical research in బీజింగ్. We have assembled a group of famous clinical research professionals from China, as well as a full clinical research support team. Building on its clinical research capabilities, the hospital leverages Beijing’s strong foundation in basic research, entrepreneurial firms, and research institutions to establish a high-level ecosystem for medical innovation.

As one of the flagship hospitals of the GoBroad Healthcare Group, which was founded in 2017, Beijing GoBroad Hospital is a pioneer and practitioner of the research hospital pattern. The group’s four main business sectors are the Center for Challenging and Critical Care Medicine, Clinical Research Center, Precision Diagnosis Center, and Data Intelligence Center. The organization has assembled prominent clinical experts with the goal of advancing medical innovation, and they have constructed an integrated platform that facilitates industry and clinical collaboration.

మెజారిటీ సిబ్బంది క్లినికల్ ఇన్నోవేషన్‌కు మారడానికి నిపుణుల సహాయాన్ని అందించడానికి అంకితభావంతో ఉన్నారు. ఎర్లీ క్లినికల్ రీసెర్చ్ సెంటర్, సెంట్రల్ లాబొరేటరీ, ఇమేజింగ్ సెంటర్, పాథాలజీ సెంటర్, క్లినికల్ ఫార్మకాలజీ, కార్డియాక్ సేఫ్టీ కోసం క్లినికల్ ఎవాల్యుయేషన్ సెంటర్, మెడికల్ అండ్ స్టాటిస్టికల్ టీమ్‌లు మరియు మొదలైనవి ప్రత్యేక సేవా బృందాలకు ఉదాహరణలు. స్థాపించబడినప్పటి నుండి, సంస్థ వందలాది అత్యాధునిక ఔషధ సంస్థలతో కలిసి పనిచేయడం మరియు వివిధ ట్రయల్స్ నిర్వహించడం ద్వారా విస్తారమైన జ్ఞానాన్ని సేకరించడం ద్వారా వేగంగా అభివృద్ధి చెందింది. అదనంగా, ఇది పదివేల మంది కష్టతరమైన మరియు తీవ్ర అనారోగ్యంతో ఉన్న రోగులకు తాజా ఆశను ఇచ్చింది.

• లుకేమియా;
• Lymphoma;
• మైలోమా:
• మైలోడిస్ప్లాస్టిక్ సిండ్రోమ్ (MDS);
• Myelodysplastic/myeloproliferative neoplasms (MDS/MPN);
• తలసేమియా;
• Aplastic anemia;
• Paroxysmal nocturnal hemoglobinuria (PNH);
• థ్రోంబోసైటోపెనియా;
• రక్తం గడ్డకట్టే లోపాలు;
• Hemophagocytic lymphohistiocytosis;
• X-linked agammaglobulinemia;
• Idiopathic neutropenia;
• Wiskott-Aldrich syndrome (WAS);
• ఇమ్యునో డిఫిషియెన్సీస్;
• Chronic granulomatous disease;
• Hyperimmunoglobulin M syndrome;
• Hematopoietic disorders;
• Other blood disorders.

ఆసుపత్రి బీజింగ్‌లోని చాంగ్పింగ్ లైఫ్ సైన్స్ పార్క్‌లో ఉంది, ఇది సుమారుగా 100,000 చదరపు మీటర్ల విస్తీర్ణంలో ఉంది. 500 పడకలు, 100 పడకలు ప్రారంభ దశ పరిశోధనలకు అంకితం చేయాలని ప్రణాళిక చేయబడింది. ఘన కణితులు, హెమటోలాజిక్ ట్యూమర్‌లు మరియు బ్రెయిన్ సైన్స్‌లో ప్రత్యేకత కలిగిన ఈ ఆసుపత్రి అధికారికంగా జూలై 2023లో ప్రారంభించబడింది.

భవనం 1, నెం.4 సైన్స్ పార్క్ రోడ్, లైఫ్ సైన్స్ పార్క్, చాంగ్పింగ్ జిల్లా, బీజింగ్, చైనా – 102200

Hematology Department 1: General Hematology
Leading specialist, Tong Chun Rong has 30 years of clinical and laboratory experience in hematologic diseases. The department provides various types of diagnosis and treatment for blood diseases, such as:

• లుకేమియా
• లింఫోమా
• బహుళ మైలోమా and other hematologic tumors;
• thalassemia and other anemic diseases;
• thrombocytopenia and other blood clotting disorders.

The department specializes in comprehensive diagnosis, individualized treatment of hematologic diseases, and treatment of hematologic tumors with such methods as:

• కీమోథెరపీ
• లక్ష్య చికిత్స
• రేడియేషన్ థెరపీ

In addition, the department is involved in developing overall treatment strategies. The medical team adjusts the dosage of drugs based on their metabolism and monitors concentrations, ensuring the safety and efficacy of treatment.

Hematology Department 2: Transplantation

Leading specialist Wu Tong has 30 years of experience in hematopoietic stem cell transplantation. She has successfully performed more than 4,000 allogeneic transplants.
The department team has extensive experience in the application of hematopoietic stem cell transplantation to treat hematopoietic disorders and immunodeficiencies, such as:

• లుకేమియా;
• myelodysplastic syndrome (MDS);
• myelodysplastic/myeloproliferative neoplasms (MDS/MPN);
• లింఫోమా;
• బహుళ మైలోమా;
• అప్లాస్టిక్ అనీమియా;
• paroxysmal nocturnal hemoglobinuria (PNH);
• హిమోఫాగోసైటిక్ లింఫోహిస్టియోసైటోసిస్ (familial and Epstein-Barr virus-associated);
• X-linked agammaglobulinemia;
• idiopathic neutropenia;
• Wiskott-Aldrich syndrome (WAS);
• severe combined immunodeficiencies;
• chronic granulomatous disease;
• hyperimmunoglobulin M syndrome;
• pediatric inflammatory bowel disease and other blood disorders.

Division of Hematology 3: Pediatric Lymphoma

Leading specialist Zhang Yong Hong has more than 30 years of clinical experience in pediatric hematologic diseases, particularly in treating lymphoma and leukemia. Zhang Yong Hong is the scientific director of the professional group specializing in lymphoma at Beijing Children’s Hospital and the founding director of China-Net Children’s Lymphoma.

The department diagnoses and treats various types of lymphomas, including lymphoblastic lymphoma, Burkitt’s lymphoma, anaplastic large-cell lymphoma, and హాడ్కిన్స్ లింఫోమా. The diagnosis and treatment process involves advanced programs that take into account the different types of pathologies, risk factors, and the results of stepwise evaluation during therapy. Treatment is continuously adjusted according to the results obtained. The 5-year complication-free survival rate for all types of నాన్-హాడ్కిన్స్ లింఫోమా is more than 80% and more than 90% for Hodgkin’s lymphoma.

Hematology Department 4: Adult Lymphoma

Ke Xiao Yan, a renowned lymphoma specialist, heads the department. The department employs a second-generation treatment program, integrating patients’ clinical parameters for more accurate prognosis and drug selection.

The department team is exploring new treatment strategies for patients with refractory lymphoma. When relapse occurs after individualized therapy, patients are given an additional course of treatment with 75% efficacy. For patients with relapsed lymphoma or myeloma affecting the central nervous system, individualized treatment is used with 88.9% efficacy.

The medical team creates an individualized treatment plan based on an accurate diagnosis, including targeted therapy, high-dose chemotherapy, and hematopoietic stem cell transplantation.

వైద్య ప్రయోగశాల

The medical laboratory covers an area of approximately 5,000 square meters and receives investments of more than 100 million yuan. The laboratory has a team of leading experts from various disciplines with doctoral and master’s degrees. The laboratory specializes in conducting a wide range of clinical tests, such as:

• routine clinical tests;
• cell morphology;
• cytochemistry;
• histopathology and immunohistochemistry;
• flow cytometry analysis;
• fluorescence in situ hybridization (FISH);
• genetic analysis (including genetic analyses of hematologic tumors, genetic blood diseases, and genetic predispositions to blood diseases, genetic analysis of drug metabolism, pathogenic genes, and others);
• analysis of pathogens, drug concentrations, and cytokines.

These tests help physicians provide more accurate and individualized treatment, increasing efficacy, reducing side effects, and eliminating pain syndromes. The medical laboratory also collects, separates, and cryopreserves blood cell components and hematopoietic stem cells.

Pathoanatolical Department 
Dr. Guo Li Gai heads the department and specializes in the pathology of the lymphatic and hematopoietic systems (molecular pathology). He has extensive experience in diagnosing diseases, particularly leukemia, myelodysplastic syndrome (MDS), and myelodysplastic/myeloproliferative neoplasms (MDS/MPN). Since 2006, the doctor has published over 20,000 bone marrow biopsy reports. Since 2014, Guo Li Gai has studied thousands of clinical lymphoma cases and has accumulated rich experience diagnosing hematologic diseases and lymphomas.

To make accurate diagnoses, the pathology department has established a stereoscopic integrated diagnostic model (MICM), which includes morphology (M), immunology (I), cytogenetics (C), and molecular science (M). The department works closely with the మేయో క్లినిక్.